✦ LIBER ✦

Cerebrospinal fluid tau, phospho-tau181 and β-amyloid1−42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease

✍ Scribed by E. N. Kapaki; G. P. Paraskevas; N. G. Tzerakis; C. Sfagos; A. Seretis; E. Kararizou; D. Vassilopoulos

Book ID: 111064910
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 559 KB
Volume: 14
Category: Article
ISSN: 1351-5101
DOI: 10.1111/j.1468-1331.2006.01593.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cerebrospinal fluid tau, Aβ1–42 and infl

Cerebrospinal fluid tau, Aβ1–42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia

✍ J.P. Jia; R. Meng; Y.X. Sun; W.J. Sun; X.M. Ji; L.F. Jia 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Performance of improved cerebrospinal fl

Performance of improved cerebrospinal fluid Aβ42 and tau assays in differentiating Alzheimer's disease and MCI from control subjects

✍ Flora Berisha; Paul Rhyne; Carol Gleason; Pankaj Oberoi; James Wilbur; Jill Dunt 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Cerebrospinal fluid β-amyloid1–42 and ta

Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele

✍ Trey Sunderland; Nadeem Mirza; Karen T. Putnam; Gary Linker; Deepa Bhupali; Rob 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Cerebral glucose metabolism, cerebrospin

Cerebral glucose metabolism, cerebrospinal fluid-β-amyloid1–42 (CSF-Aβ42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients

✍ E. Stefanova; K. Blennow; O. Almkvist; E. Hellström-Lindahl; A. Nordberg 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Longitudinal study of cerebrospinal flui

Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan

✍ M. Kanai; E. Matsubara; K. Isoe; K. Urakami; K. Nakashima; H. Arai; H. Sasaki; K 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 919 KB

To clarify the alterations of tau, amyloid beta protein (A beta) 1-40 and A beta1-42(43) in the cerebrospinal fluid (CSF) that accompany normal aging and the progression of Alzheimer's disease (AD), CSF samples of 93 AD patients, 32 longitudinal subjects among these 93 AD patients, 33 patients with

The diagnostic value of tau protein, β-a

The diagnostic value of tau protein, β-amyloid (1–42) and their ratio for the discrimination of alcohol-related cognitive disorders from Alzheimer's disease in the early stages

✍ Elisabeth Kapaki; Ioannis Liappas; George P. Paraskevas; Ilia Theotoka; Andreas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

Background Chronic and heavy alcohol abuse or dependence may result in impaired cognition and dementia. The increased risk of Alzheimer's disease (AD) in older individuals interferes with the differential diagnosis, especially when dealing with elderly patients with a long history of alcohol abuse.